ATE47035T1 - Kit oder vorrichtung und methode zum verabreichen von gangliosiden und deren derivate durch inhalation und dafuer geeignete pharmazeutische zusammensetzungen. - Google Patents

Kit oder vorrichtung und methode zum verabreichen von gangliosiden und deren derivate durch inhalation und dafuer geeignete pharmazeutische zusammensetzungen.

Info

Publication number
ATE47035T1
ATE47035T1 AT84307403T AT84307403T ATE47035T1 AT E47035 T1 ATE47035 T1 AT E47035T1 AT 84307403 T AT84307403 T AT 84307403T AT 84307403 T AT84307403 T AT 84307403T AT E47035 T1 ATE47035 T1 AT E47035T1
Authority
AT
Austria
Prior art keywords
gangliosides
kit
inhalation
administration
derivatives
Prior art date
Application number
AT84307403T
Other languages
English (en)
Inventor
Valle Francesco Della
Aurelio Romeo
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Application granted granted Critical
Publication of ATE47035T1 publication Critical patent/ATE47035T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT84307403T 1983-11-08 1984-10-26 Kit oder vorrichtung und methode zum verabreichen von gangliosiden und deren derivate durch inhalation und dafuer geeignete pharmazeutische zusammensetzungen. ATE47035T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8349288A IT1212896B (it) 1983-11-08 1983-11-08 Metodo di somministrazione per via inalatoria di gangliosidi e derivati, e composizioni farmaceutiche relative
EP84307403A EP0145209B1 (de) 1983-11-08 1984-10-26 Kit oder Vorrichtung und Methode zum Verabreichen von Gangliosiden und deren Derivate durch Inhalation und dafür geeignete pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE47035T1 true ATE47035T1 (de) 1989-10-15

Family

ID=11270228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84307403T ATE47035T1 (de) 1983-11-08 1984-10-26 Kit oder vorrichtung und methode zum verabreichen von gangliosiden und deren derivate durch inhalation und dafuer geeignete pharmazeutische zusammensetzungen.

Country Status (22)

Country Link
US (1) US4639437A (de)
EP (1) EP0145209B1 (de)
JP (1) JPS60132920A (de)
KR (1) KR850003503A (de)
AT (1) ATE47035T1 (de)
AU (1) AU569920B2 (de)
BE (1) BE900994A (de)
CH (1) CH662278A5 (de)
DE (1) DE3480053D1 (de)
DK (1) DK160129C (de)
ES (1) ES8608532A1 (de)
FR (1) FR2554346B1 (de)
GR (1) GR80853B (de)
IL (1) IL73292A (de)
IN (1) IN163563B (de)
IT (1) IT1212896B (de)
LU (1) LU85633A1 (de)
MX (1) MX163574B (de)
NO (1) NO844443L (de)
NZ (1) NZ209974A (de)
PT (1) PT79466B (de)
ZA (1) ZA848541B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1177863B (it) * 1984-07-03 1987-08-26 Fidia Farmaceutici Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche
JPS6368526A (ja) * 1986-09-11 1988-03-28 Mect Corp シアリルグリセライドからなる神経障害疾患治療剤
US4937232A (en) * 1986-09-15 1990-06-26 Duke University Inhibition of protein kinase C by long-chain bases
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
US5624898A (en) 1989-12-05 1997-04-29 Ramsey Foundation Method for administering neurologic agents to the brain
ATE156704T1 (de) * 1989-12-05 1997-08-15 Ramsey Foundation Neurologische wirkstoffe zur nasalen verabreichung an das gehirn
US6407061B1 (en) * 1989-12-05 2002-06-18 Chiron Corporation Method for administering insulin-like growth factor to the brain
IT1249034B (it) * 1990-06-29 1995-02-11 Fidia Spa Impiego del monosialoganglioside gm1 e del suo derivato estere interno per impedire l'instaurarsi della tolleranza nell'uomo all'effetto analgesico della morfina e analoghi
WO1992017189A1 (en) * 1991-03-29 1992-10-15 The Regents Of The University Of California Gangliosides with immunosuppressive activity
WO1993002686A1 (en) * 1991-07-31 1993-02-18 The Regents Of The University Of California Gangliosides with immunosuppressive ceramide moieties
US5567684A (en) * 1994-09-14 1996-10-22 The Regents Of The University Of California Synthetic ganglioside derivatives
US7273618B2 (en) * 1998-12-09 2007-09-25 Chiron Corporation Method for administering agents to the central nervous system
JP2005527467A (ja) 2001-08-29 2005-09-15 ネオーズ テクノロジーズ， インコーポレイテッド 新規な合成ガングリオシド誘導体およびその組成物
MXPA05009480A (es) 2003-03-06 2006-02-22 Neose Technologies Inc Metodos y composiciones para la sintesis enzimatica de gangliosidos.
CU23317A1 (es) 2005-07-22 2008-10-22 Ct De Investigacia N Y Desarro Formulaciones nasales de eporh con bajo contenido de ã cido siã lico para el tratamiento de enfermedades del sistema nervioso central
EP3175857A1 (de) 2009-03-25 2017-06-07 Seneb Biosciences Inc. Glycolipide zur behandlung von erkrankungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL262354A (de) * 1960-03-17
US3282781A (en) * 1960-11-25 1966-11-01 Merck & Co Inc Inhalant compositions
US4094968A (en) * 1972-09-06 1978-06-13 Burroughs Wellcome Co. Treatment for allergy and method of composition thereof
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
US4476119A (en) * 1981-08-04 1984-10-09 Fidia S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions

Also Published As

Publication number Publication date
JPH0211570B2 (de) 1990-03-14
BE900994A (nl) 1985-05-07
DK160129C (da) 1991-07-01
DK505584A (da) 1985-05-09
LU85633A1 (fr) 1985-06-04
CH662278A5 (fr) 1987-09-30
IT1212896B (it) 1989-11-30
ES8608532A1 (es) 1986-07-16
MX163574B (es) 1992-06-02
IT8349288A0 (it) 1983-11-08
PT79466A (en) 1984-12-01
ES537300A0 (es) 1986-07-16
IL73292A (en) 1988-07-31
PT79466B (en) 1986-12-12
DE3480053D1 (en) 1989-11-16
DK160129B (da) 1991-02-04
IN163563B (de) 1988-10-08
IL73292A0 (en) 1985-01-31
AU569920B2 (en) 1988-02-25
JPS60132920A (ja) 1985-07-16
US4639437A (en) 1987-01-27
FR2554346A1 (fr) 1985-05-10
FR2554346B1 (fr) 1987-11-20
DK505584D0 (da) 1984-10-23
EP0145209A3 (en) 1986-11-26
GR80853B (en) 1985-02-26
EP0145209A2 (de) 1985-06-19
AU3518984A (en) 1985-05-16
KR850003503A (ko) 1985-06-20
ZA848541B (en) 1985-06-26
NZ209974A (en) 1987-02-20
NO844443L (no) 1985-05-09
EP0145209B1 (de) 1989-10-11

Similar Documents

Publication Publication Date Title
ATE47035T1 (de) Kit oder vorrichtung und methode zum verabreichen von gangliosiden und deren derivate durch inhalation und dafuer geeignete pharmazeutische zusammensetzungen.
DE60216830D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE3854741T3 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
EP0401903A3 (de) Verwendung von Vanilloiden zur Behandlung von Erkrankungen der Atemwege
KR870700599A (ko) 카르복실산유도체, 그의 제조방법, 이화합물을 함유한 약제조성물 및 그의 용도
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
ES1022449Y (es) Aparato terapeutica para tratamiento de sintomas ocasionados por enfermedades.
DK229984A (da) 4-oxothiazolidin-2-yliden-acetamidderivater
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
IT8322949A0 (it) Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello.
PT95566A (pt) Metodo para a utilizacao de derivados de 2-oxindole substituidos na posicao 3 como inibidores da biossintese de interleuquina-1
DK0950053T3 (da) Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater
ATE94758T1 (de) Verwendung von gangliosiden zur behandlung der dysfunktion des autonomen nervensystems bei der chagas-krankheit.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee